These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18780866)

  • 41. [Antioxidant vitamins - too much of a good thing?].
    Holz FG; Hunt S
    Ophthalmologe; 2007 Jul; 104(7):617. PubMed ID: 17598112
    [No Abstract]   [Full Text] [Related]  

  • 42. Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be not better.
    Sasse AD; Lima JP; Sasse EC; Santos LV
    J Clin Oncol; 2009 Dec; 27(35):e253; author reply e254. PubMed ID: 19884522
    [No Abstract]   [Full Text] [Related]  

  • 43. Antioxidant therapy effectiveness: an up to date.
    Iannitti T; Palmieri B
    Eur Rev Med Pharmacol Sci; 2009; 13(4):245-78. PubMed ID: 19694341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The outlook for the use of antioxidants in the combined treatment of malignant tumors].
    Sukolinskiĭ VN
    Vopr Onkol; 1990; 36(2):138-44. PubMed ID: 2180207
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of measurement error on response rates.
    Warr D; McKinney S; Tannock I
    Cancer Treat Rep; 1985 Oct; 69(10):1127-32. PubMed ID: 4042092
    [No Abstract]   [Full Text] [Related]  

  • 46. Reirradiation and concurrent chemotherapy after salvage surgery: pay now or pay later.
    Wong SJ; Spencer S
    J Clin Oncol; 2008 Dec; 26(34):5500-1. PubMed ID: 18936468
    [No Abstract]   [Full Text] [Related]  

  • 47. Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
    Nabhan C
    Clin Cancer Res; 2008 Jul; 14(13):4353. PubMed ID: 18594019
    [No Abstract]   [Full Text] [Related]  

  • 48. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
    Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
    J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
    [No Abstract]   [Full Text] [Related]  

  • 49. Sensitizers and protectors of radiation and chemotherapy.
    Poggi MM; Coleman CN; Mitchell JB
    Curr Probl Cancer; 2001; 25(6):334-411. PubMed ID: 11740469
    [No Abstract]   [Full Text] [Related]  

  • 50. [The antioxidant hypothesis is dead. How many Danes died with it?].
    Astrup AV
    Ugeskr Laeger; 2006 Aug; 168(34):2786. PubMed ID: 16942695
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of hypocaloric diet with supplemented biologically active substances with antioxidant activity on clinicometabolic parameters in type 2 diabetes mellitus patients].
    Sharafetdinov KhKh; Plotnikova OA; Zykina VV; Alekseeva RI; Mal'tsev GIu; Kaganov BS
    Vopr Pitan; 2009; 78(2):57-62. PubMed ID: 19514345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is response rate relevant to the phase II trial design of targeted agents?
    Dowlati A; Fu P
    J Clin Oncol; 2008 Mar; 26(8):1204-5. PubMed ID: 18285601
    [No Abstract]   [Full Text] [Related]  

  • 54. Antioxidant studies need a change of direction.
    Shishehbor MH; Hazen SL
    Cleve Clin J Med; 2004 Apr; 71(4):285-8. PubMed ID: 15117169
    [No Abstract]   [Full Text] [Related]  

  • 55. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of dietary supplements on hemostasis: a case of bleeding in context of research and surveillance.
    Palmer ME
    Thromb Res; 2005; 117(1-2):33-8; discussion 39-42. PubMed ID: 16182344
    [No Abstract]   [Full Text] [Related]  

  • 57. Discrete event simulation applied to pediatric phase I oncology designs.
    Barrett J; Skolnik J; Jayaraman B; Patel D; Adamson P
    Clin Pharmacol Ther; 2008 Dec; 84(6):729-33. PubMed ID: 18923388
    [No Abstract]   [Full Text] [Related]  

  • 58. Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer.
    Crohns M; Liippo K; Erhola M; Kankaanranta H; Moilanen E; Alho H; Kellokumpu-Lehtinen P
    Clin Biochem; 2009 Aug; 42(12):1236-45. PubMed ID: 19445914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin E. Assessing the risks and benefits.
    Mayo Clin Womens Healthsource; 2006 Mar; 10(3):1-2. PubMed ID: 16489282
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antioxidants - no reason for a reassessment].
    Biesalski HK
    Ophthalmologe; 2007 Jul; 104(7):618-9. PubMed ID: 17594101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.